General Information of Drug Transporter (DT)
DT ID DTD0376 Transporter Info
Gene Name SLC49A1
Transporter Name Feline leukemia virus subgroup C receptor-related protein 1
Gene ID
28982
UniProt ID
Q9Y5Y0
Post-Translational Modification of This DT
Overview of SLC49A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

265

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC49A1 Asparagine 265 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

273

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC49A1 Asparagine 273 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A1 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 56 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

61

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 61 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC49A1 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

95

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 95 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC49A1 [5] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

96

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 96 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC49A1 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

104

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 104 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC49A1 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

536

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Serine 536 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A1 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

46

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 46 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A1 [3] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

69

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 69 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC49A1 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

90

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 90 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC49A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

101

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 101 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC49A1 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

401

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 401 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC49A1 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

417

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 417 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC49A1 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

419

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 419 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC49A1 [10] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

538

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Threonine 538 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A1 [11] , [14]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

22

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Tyrosine 22 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A1 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

398

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A1 Tyrosine 398 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A1 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

33

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A1 Lysine 33 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A1 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

322

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A1 Lysine 322 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC49A1 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

530

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A1 Lysine 530 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: FLVC1_HUMAN)
2 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
3 Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells. Biochem Biophys Res Commun. 2018 Oct 20;505(1):187-193.
4 HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
5 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
6 Residual tissue repositories as a resource for population-based cancer proteomic studies. Clin Proteomics. 2018 Aug 3;15:26.
7 Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
8 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
9 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
10 Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
11 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
12 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
13 Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
14 Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
15 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
16 Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin. J Proteome Res. 2012 Feb 3;11(2):796-807.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.